<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The extent and severity of neuronal damage is different in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> with reperfusion compared to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and no reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate the role of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion injury, in vivo microdialysis was performed to examine the dynamic profile of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> in the hippocampus in a transient (30 min) or permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) in Wistar rats </plain></SENT>
<SENT sid="2" pm="."><plain>The extracellular concentration of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> in the cornu ammonis (CA)1 sector of the ipsilateral hippocampus showed a significant but transient elevation of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> for both groups immediately following ischemic insult </plain></SENT>
<SENT sid="3" pm="."><plain>The initial high peak in <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> levels in the transient MCAo group was followed by two secondary elevations in <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> at 50 min and 90 min after initialization of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>The histopathological outcome was also different in the two groups </plain></SENT>
<SENT sid="5" pm="."><plain>The observation that <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> releases occurred in the early reperfusion phase provided an evidence of additional excitotoxicity of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and thereby a therapeutic base for extended use of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> in the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury </plain></SENT>
</text></document>